Search Results

You are looking at 31 - 40 of 261 items for :

  • endocrine trends x
  • User-accessible content x
Clear All
Open access

K G Samsom, L M van Veenendaal, G D Valk, M R Vriens, M E T Tesselaar, and J G van den Berg

hereditary syndromes, for example multiple endocrine neoplasia (MEN) type 1 or 2 and Von Hippel Lindau disease. The reported incidence of SI-NETs has increased over the last four decades, from 0.2 per 100,000 individuals in 1973 to 1.25 per 100

Open access

Shane M Regnier, Andrew G Kirkley, Daniel Ruiz, Wakanene Kamau, Qian Wu, Kurunthachalam Kannan, and Robert M Sargis

in a diet enriched in saturated and trans fats as well as simple carbohydrates that promote the development of obesity and diabetes ( 7 , 8 ). Recently, exposures to endocrine-disrupting chemicals (EDCs) have been implicated as novel metabolic

Open access

Amir Bashkin, Eliran Yaakobi, Marina Nodelman, and Ohad Ronen

treatment or work-up during hospitalization. In only nine patients was it possible to state clearly that the test was helpful because it led to treatment change in a justified manner. A trend toward statistically significant correlation was found only

Open access

Marcus Quinkler, Bertil Ekman, Claudio Marelli, Sharif Uddin, Pierre Zelissen, Robert D Murray, and on behalf of the EU-AIR Investigators

the recent Endocrine Society Clinical Practice guideline summarising therapy in AI ( 14 ), prednisolone (3–5 mg/day) is suggested as an alternative to hydrocortisone, particularly in patients with reduced compliance; however, currently, prospective

Open access

Enrique Soto-Pedre, Paul J Newey, John S Bevan, and Graham P Leese

Introduction Hyperprolactinaemia is a common condition in endocrine practice ( 1 ). It may occur in men and women at any age, and its prevalence and incidence depend on the study population. Its epidemiology in the general population has been

Open access

Kaisa K Ivaska, Maikki K Heliövaara, Pertti Ebeling, Marco Bucci, Ville Huovinen, H Kalervo Väänänen, Pirjo Nuutila, and Heikki A Koistinen

, acquisition of data, interpretation of data, and revision of the article. All authors approved the final version of the article. References 1 Fukumoto S Martin TJ . Bone as an endocrine organ . Trends in Endocrinology and Metabolism 2009 20 230

Open access

Rosalie Cabry, Philippe Merviel, Aicha Madkour, Elodie Lefranc, Florence Scheffler, Rachel Desailloud, Véronique Bach, and Moncef Benkhalifa

, benomyl, and mancozeb Pyrethroids , such as permethrin Triazines , such as atrazine Many pesticides are known to be endocrine-disrupting chemicals (EDCs), defined as ‘exogenous agents, that are potentially capable of synthesis, secretion

Open access

Nadine M Vaninetti, David B Clarke, Deborah A Zwicker, Churn-Ern Yip, Barna Tugwell, Steve Doucette, Chris Theriault, Khaled Aldahmani, and Syed Ali Imran

epidemiological trends of these two entities in order to understand their implications on diagnostic strategies and long-term management of these lesions. Materials and methods Study population and HNP database The province of Nova Scotia, Canada has a

Open access

I Savchuk, M L Morvan, J P Antignac, K Gemzell-Danielsson, B Le Bizec, O Söder, and K Svechnikov

-placental unit . Endocrine Reviews 2011 32 317 – 355 . ( doi:10.1210/er.2010-0001 ) 2 Hanley NA Rainey WE Wilson DI Ball SG Parker KL. Expression profiles of SF-1, DAX1, and CYP17 in the human fetal adrenal gland: potential

Open access

Charlotte Höybye, Andreas F H Pfeiffer, Diego Ferone, Jens Sandahl Christiansen, David Gilfoyle, Eva Dam Christoffersen, Eva Mortensen, Jonathan A Leff, and Michael Beckert

. Clinical safety parameters were stable with similar directional trends between TransCon GH and Omnitrope. After repeat doses, TransCon GH demonstrated a linear, dose-dependent increase in GH peak exposure without accumulation and a similar C max as